Desvenlafaxine for the Treatment of Hot Flashes in Women With Breast Cancer Taking Tamoxifen: a Randomized, Double-blind, Placebo-controlled Study
Not yet recruiting
Phase of Trial: Phase IV
Latest Information Update: 30 Nov 2017
At a glance
- Drugs Desvenlafaxine (Primary)
- Indications Hot flashes; Vasomotor symptoms
- Focus Therapeutic Use
- 24 Nov 2017 Planned number of patients changed from 200 to 339.
- 24 Nov 2017 Planned End Date changed from 1 Dec 2018 to 1 Feb 2019.
- 24 Nov 2017 Planned primary completion date changed from 1 Jun 2018 to 1 Oct 2018.